PMID- 21822280 OWN - NLM STAT- MEDLINE DCOM- 20111108 LR - 20211020 IS - 1545-9985 (Electronic) IS - 1545-9993 (Print) IS - 1545-9985 (Linking) VI - 18 IP - 9 DP - 2011 Aug 7 TI - Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. PG - 984-9 LID - 10.1038/nsmb.2092 [doi] AB - To our knowledge, no structural study to date has characterized, in an intact receptor, the coupling of conformational change in extracellular domains through a single-pass transmembrane domain to conformational change in cytoplasmic domains. Here we examine such coupling, and its unexpected complexity, using nearly full-length epidermal growth factor receptor (EGFR) and negative-stain EM. The liganded, dimeric EGFR ectodomain can couple both to putatively active, asymmetrically associated kinase dimers and to putatively inactive, symmetrically associated kinase dimers and monomers. Inhibitors that stabilize the active or inactive conformation of the kinase active site, as well as mutations in the kinase dimer interface and a juxtamembrane phosphorylation site, shift the equilibrium among the three kinase association states. This coupling of one conformation of an activated receptor ectodomain to multiple kinase-domain arrangements reveals previously unanticipated complexity in transmembrane signaling and facilitates regulation of receptor function in the juxtamembrane and cytoplasmic environments. FAU - Mi, Li-Zhi AU - Mi LZ AD - Immune Disease Institute and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA. FAU - Lu, Chafen AU - Lu C FAU - Li, Zongli AU - Li Z FAU - Nishida, Noritaka AU - Nishida N FAU - Walz, Thomas AU - Walz T FAU - Springer, Timothy A AU - Springer TA LA - eng GR - P01 HL048675/HL/NHLBI NIH HHS/United States GR - HHMI/Howard Hughes Medical Institute/United States GR - HL-48675/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110807 PL - United States TA - Nat Struct Mol Biol JT - Nature structural & molecular biology JID - 101186374 RN - 0 (Ligands) RN - EC 2.7.10.1 (ErbB Receptors) SB - IM CIN - Nat Struct Mol Biol. 2012 Jan;19(1):1-3. PMID: 22218287 MH - Catalytic Domain MH - Dimerization MH - ErbB Receptors/*chemistry/genetics/ultrastructure MH - Humans MH - Ligands MH - Mutation MH - Protein Structure, Tertiary PMC - PMC4117315 MID - NIHMS609904 EDAT- 2011/08/09 06:00 MHDA- 2011/11/09 06:00 PMCR- 2014/07/31 CRDT- 2011/08/09 06:00 PHST- 2011/02/02 00:00 [received] PHST- 2011/05/25 00:00 [accepted] PHST- 2011/08/09 06:00 [entrez] PHST- 2011/08/09 06:00 [pubmed] PHST- 2011/11/09 06:00 [medline] PHST- 2014/07/31 00:00 [pmc-release] AID - nsmb.2092 [pii] AID - 10.1038/nsmb.2092 [doi] PST - epublish SO - Nat Struct Mol Biol. 2011 Aug 7;18(9):984-9. doi: 10.1038/nsmb.2092.